Table I.
Characteristics | All VLBWs | ELBWs (<1000 g) | ||||
---|---|---|---|---|---|---|
No EVC001 (N = 301) | EVC001 (N = 182) | P value | No EVC001 (N = 125) | EVC001 (N = 75) | P value | |
Female sex, % | 52.2 | 42.3 | .04* | 53.6 | 44.0 | .19* |
Birth weight, g, mean (range) | 1045.4 (325–1490) | 1048.0 (358–1498) | .97* | 758.1 (325–992) | 779.1 (358–999) | .38* |
Gestational age at birth, wk, mean (range) | 28.3 (23.3–35.1) | 28.4 (23.6–34.9) | .46* | 26.0 (23.3–31.7) | 26.6 (23.6–34.1) | .17* |
SGA status, % | 15.9 | 14.8 | .74† | 19.2 | 16.0 | .57† |
Cesarean delivery, % | 77.1 | 74.2 | .47† | 80.0 | 76.0 | .51† |
CHD, %‡ | 4.0 | 7.1 | .13† | 3.2 | 5.3 | .71† |
Antenatal steroid use, % | 90.4 | 83.5 | .03† | 90.4 | 85.3 | .28† |
By the Wilcoxon rank-sum test.
By the Pearson χ2 test.
Nonhemodynamically significant.